Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Ramjattan · SciRah

Researcher profile · Semantic Scholar

B. Ramjattan

Share profile

B. Ramjattan — researcher profile on SciRah

h-index: 9
Works: 9
Citations: 730

Most-cited papers

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.
B. Romanowski, P. D. de Borba, P. Naud, C. Roteli-Martins +28 more
2009The Lancet389 citations
Semantic Scholar
Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination
B. Romanowski, T. Schwarz, L. Ferguson, Murdo Ferguson +9 more
2014Human Vaccines & Immunotherapeutics107 citations Open access
Semantic Scholar
A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
G. Irving, János Pénzes, B. Ramjattan, M. Cousins +7 more
2011Journal of Pain71 citations Open access
Semantic Scholar
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
B. Romanowski, Tino F. Schwarz, L. Ferguson, K. Peters +8 more
2011Human Vaccines49 citations Open access
Semantic Scholar
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial
A. Ramanakumar, P. Naud, C. Roteli-Martins, N. D. de Carvalho +11 more
2016BMJ Open42 citations Open access
Semantic Scholar
Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA
F. Struyf, B. Colau, C. Wheeler, P. Naud +26 more
2014Clinical and Vaccine Immunology24 citations Open access
Semantic Scholar
Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials.
B. Ramjattan, Denis J G Callaghan, U. Theiss
2002Clinical Therapeutics20 citations
Semantic Scholar
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine
N. Folschweiller, U. Behre, M. Dionne, P. Durando +15 more
2019Journal of Infectious Diseases16 citations Open access
Semantic Scholar
Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women
M. El-Zein, A. Ramanakumar, P. Naud, C. Roteli-Martins +9 more
2019Sexually Transmitted Diseases13 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Romanowski×4
Invite
B. Romanowski — researcher profile on SciRah
P. Naud×4
Invite
P. Naud — researcher profile on SciRah
G. Dubin×4
Invite
G. Dubin — researcher profile on SciRah
K. Peters×4
Invite
K. Peters — researcher profile on SciRah

C. Roteli-Martins

×3

Invite

C. Roteli-Martins — researcher profile on SciRah

N. D. de Carvalho×3

Invite

N. D. de Carvalho — researcher profile on SciRah

Invite

J. Teixeira — researcher profile on SciRah

Invite

D. Harper — researcher profile on SciRah

Invite

A. Moscicki — researcher profile on SciRah

Invite

T. Schwarz — researcher profile on SciRah

Invite

L. Ferguson — researcher profile on SciRah

Invite

M. Dionne — researcher profile on SciRah